BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2003
View Archived Issues
New tricyclic macrolide antibiotics identified at Abbott
Read More
Merck describes new selective androgen receptor modulators for osteoporosis therapy
Read More
Another series of chemokine CCR2 modulators newly identified at Merck
Read More
Novel anti-herpes virus agents prepared and tested by GSK team
Read More
Genelabs patent covers new NS5B inhibitors for HCV infection
Read More
Pivotal stage of AI-700 phase III program commences
Read More
Kinexium to manage development of new departments at Generex
Read More
Phase I trial tests FG-3019 in IPF patients
Read More
Second approvable letter for Symlin
Read More
Naropin recommended for E.U. approval for new indication
Read More
Second phase II trial for Corus-1030
Read More
CTCE-9908 enters phase I testing
Read More
Enrollment goal reached for phase III Xibrom trial
Read More
Orphan drug designation for Photopoint MV-2101
Read More
BAMF Technology to be transitioned to Eclipse Diagnostics
Read More
Oxford BioMedica oncology pipeline update
Read More
deCODE achieves milestones in Roche DNA-based diagnostics alliance
Read More
MLN-2222 enters phase I
Read More
Clinical effects of PKC-412 in acute myeloid leukemia
Read More
Antitumor activity of thalidomide analogues in hematological malignancies
Read More
Cardioprotection against ischemia/reperfusion injury via PPARalpha activation shown in mice
Read More
Septic diaphragm dysfunction attenuated with geranylgernaylacetone induction of HSD70 in rats
Read More
NDA for lower dose Yasmin accepted for filing
Read More
XTL Biopharmaceuticals reviews recent developments
Read More
GW-4064, a FXR agonist, provides hepatoprotection in rat models of cholestasis
Read More